Literature DB >> 18521196

Amplification and Over-Expression of the MDM2 Gene in Human Soft Tissue Tumours.

H Patterson1, D Barnes, S Gill, J Spicer, C Fisher, M Thomas, R Grimer, C Fletcher, B Gusterson, C Cooper.   

Abstract

Purpose. Amplification of genetic sequences on chromosome 12q13 is frequently found in soft tissue tumours. However, for the MDM2 gene, over-expression of the MDM2 protein has not always been shown to accompany gene amplification, raising the possibility that amplification of genetic sequences targets alternative genes on chromosome 12q13 for over-expression. To investigate this discrepancy, we have examined 129 soft tissue tumours for amplification of the MDM2 gene using Southern analysis, and 39 of these tumours were also examined by immunohistochemical staining for MDM2 over-expression.Results. Gene amplification was identified in 14/114 (12.3%) of the malignant tumours, but was not identified in any of the benign tumours; 21/39 (54%) of the malignant tumours also demonstrated MDM2 over-expression. Within this group the MDM2 gene was over-expressed in every tumour in which the gene amplification was found, and over-expression in the absence of gene amplification was also found in an additional 10 tumours.Discussion. These data demonstrate a clear correlation between the presence of MDM2 amplification and MDM2 over-expression, and provide persuasive evidence therefore that the amplification of genetic sequences on chromosome 12q13 in soft tissue sarcomas targets the MDM2 gene for over-expression. These data also indicate that alternative mechanisms may contribute to MDM2 over-expression within some tumours.

Entities:  

Year:  1997        PMID: 18521196      PMCID: PMC2373578          DOI: 10.1080/13577149778434

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  28 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma.

Authors:  N Mandahl; S Heim; H Willén; A Rydholm; M Eneroth; M Nilbert; A Kreicbergs; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1989-09       Impact factor: 5.006

3.  Chromosomal analysis of sixteen human rhabdomyosarcomas.

Authors:  S Wang-Wuu; S Soukup; E Ballard; B Gotwals; B Lampkin
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.

Authors:  M R Stratton; S Moss; W Warren; H Patterson; J Clark; C Fisher; C D Fletcher; A Ball; M Thomas; B A Gusterson
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

6.  The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line.

Authors:  A J Garvin; W S Stanley; D D Bennett; J L Sullivan; D A Sens
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

7.  Clonal chromosome abnormalities in two liposarcomas.

Authors:  F Mertens; B Johansson; N Mandahl; S Heim; K Bennet; A Rydholm; H Willén; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1987-09

8.  The GLI gene is a member of the Kruppel family of zinc finger proteins.

Authors:  K W Kinzler; J M Ruppert; S H Bigner; B Vogelstein
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

9.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

10.  Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.

Authors:  S S Fakharzadeh; S P Trusko; D L George
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  3 in total

Review 1.  The Role of MDM2 Amplification and Overexpression in Tumorigenesis.

Authors:  Jonathan D Oliner; Anne Y Saiki; Sean Caenepeel
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

Review 2.  Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy.

Authors:  Qin Li; Guillermina Lozano
Journal:  Clin Cancer Res       Date:  2012-12-21       Impact factor: 12.531

3.  Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation.

Authors:  Zuzanna Tracz-Gaszewska; Marta Klimczak; Przemyslaw Biecek; Marcin Herok; Marcin Kosinski; Maciej B Olszewski; Patrycja Czerwińska; Milena Wiech; Maciej Wiznerowicz; Alicja Zylicz; Maciej Zylicz; Bartosz Wawrzynow
Journal:  Oncotarget       Date:  2017-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.